Anda belum login :: 18 Apr 2025 21:59 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Effects of phytosterols in diacylglycerol as part of diet therapy on hyperlipidemia in children
Oleh:
Matsuyama, Takeshi
;
Shoji, Kentaro
;
Takase, Hideto
;
Kamimaki, Isamu
;
Tanaka, Yuriko
;
Otsuka, Atsuka
;
Watanabe, Hiroyuki
;
Hase, Tadashi
;
Tokimitsu, Ichiro
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Asia Pacific Journal of Clinical Nutrition (keterangan: ada di Proquest) vol. 16 no. 01 (2007)
,
page 40.
Topik:
diacylglycerol
;
phytosterols
;
cholesterol
;
lipoprotein(a)
;
children
Ketersediaan
Perpustakaan FK
Nomor Panggil:
A27.K.2007.01
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Background: The incidence of hyperlipidemia in children is increasing in Japan , but drug therapy for such children is limited. The ingestion of 4% phytosterols-containing diacylglycerol (PS/DAG) decreases serum total cholesterol and low density lipoprotein cholesterol (LDL-C) concentrations in adults. In the present study, we examined the effect of PS/DAG as part of a diet therapy in pediatric patients with hyperlipidemia. Methods: Pediatric patients with hyperlipidemia with = 5.18mmol/L (200 mg/dL) serum total cholesterol and/or =1.70mmol/L (150 mg/dL) triglycerides (N = 22) ingested bread containing PS/DAG (total daily intake, 10g ) for 6 months. Blood chemistry was examined prior to and 2, 4, 6 months after the initiation of ingestion, and 4 months after the ingestion period. Results: No significant differences in energy intake or cholesterol intake during the study period were found. After 4 months of ingestion of PS/DAG, LDL-C, lipoprotein(a) [Lp(a)], free fatty acids and total ketone bodies decreased significantly. In seven patients with familial hypercholesterolemia, total cholesterol and remnant-like lipoprotein particles (RLP)–cholesterol also significantly decreased in addition to LDL-C and Lp(a). Conclusions: PS/DAG improves serum lipid metabolism in pediatric patients with hyperlipidemia for whom drug therapy is limited, suggesting that PS/DAG may reduce the risk of developing various diseases induced by hyperlipidemia.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)